Introduction
Glucosylceramidase (GCase, EC 3.2.1.45) is a lysosomal enzyme with 497 amino acids and three discontinuous domains [1] . It is a β -glucosidase enzyme that catalyzes the cleavage of glucosylceramide (GC) into glucose and ceramide [2] ; thereby, it plays a vital function in the degradation of complex lipids and the turnover of cellular membranes [3] . The main cellular compartment of GCase is the lysosomal membrane [4] . The activator proteins Saposin A and C, synergistically facilitate the interaction between the lipid substrate and enzyme, resulting in increased GCase enzymatic activity [5, 6] . The substrate (GC) is synthesized from the degradation of glycosphingolipids in the membranes of apoptotic white blood cells and senescent red blood cells [7] .
Gaucher disease (GD, OMIM#230800) is the most protracted health condition related to defective GCase activity [6] . The recent studies, however, further associated GCase with severe health conditions such as Parkinson's Disease (PD, OMIM#168600) [8] , Dementia with Lewy bodies (DLB, OMIM# 127750) [9] and colorectal cancer [10] . GCase is encoded by the housekeeping gene glucosylceramidase beta acid 1 (GBA1, OMIM*606463) with cytogenetic location 1q21 [11] . More than 460 mutations are reported to disrupt the GBA1 gene [12, 13] , thereby abolishing its catalytic activity [14] and decreasing enzyme stability [15] . The improper breakdown of highly hydrophobic GC results in its accumulation in the lysosomes of macrophages, leading to dysfunctions in spleen, liver, and bone marrow [16, 17] . The abnormal accumulation and storage of these substances damage tissues and organs, causing the clinical manifestations of GD [18] , which is the most frequent lysosomal storage disorder [19, 20] . GD is shown to produce a continuum of different clinical conditions, from the fatal perinatal disorder to the asymptomatic one [21] . The efficiency of enzyme replacement therapy (ERT) in GD, has led to extensive studies carried out in alternative sources of GCase [22, 23] . GD has a global occurrence of 1:50,000 [24] , but due to the founder effect, it shows a higher prevalence in Ashkenazi Jewish (Eastern European), Spanish, and Portuguese populations [25] . On the other hand, PD is a closely related neurological complication of GD, which is seen with carriers of heterozygous mutations in the GBA1 gene being susceptible to developing it [8] . Recent genetic and pathological reports suggest GBA1 mutations as critical risk factors for DLB as well [26] .
Detection of GD by GCase assay is done in a variety of human tissues, including the liver [27], brain [5] , and placenta [28] . Although any human tissue can be used to study GCase activity, in our study, we used human blood as the most readily available one. In vitro, GCase is solubilized from membranes by the extraction of lysosomal membranes using a detergent-TritonX-100 [29-31]. The non-ionic detergent Triton X-100 removes the endogenous natural lipid activators that are found in lysosomal membranes [32] , consequently rendering Glucosylceramidase inactive [29] . Therefore, the reconstitution of GCase activity requires the inclusion of an anionic detergent-sodium taurocholate [39-47]-in the assay medium. The detergent sodium taurocholate is an essential component of GCase assay and can be used with artificial substrates to measure the GCase activity with minimal interference from other β -glucosidases [30] . Sodium taurocholate inhibits nonspecific β -glucosidase, which cannot hydrolyze glucocerebroside and stimulate GCase activity [41] . Therefore a crude protein extract is suitable without the need for a purified protein. The lysosomal GCase, in vivo, is active on its natural lipid substrate glucosylceramide. In vitro, artificial substrates such as PNPG (para-Nitrophenyl-β-D-glucopyranoside) [46-48] and 4-MUG (4-methylumbelliferyl-β-D-glucopyranoside) [49-51] are very convenient ways of studying its activity due to a high yield of products that strongly absorb around 400 nm [53] .
In this work, GCase enzyme activity in human leukocytes by using an artificial substrate is studied and for the first time the inhibitory effects of glucose and δ -gluconolactone are shown. A novel protocol was designed for brief biochemical characterization of activation parameters (optimal pH, Km, and Vmax) and enzyme inhibition.
Materials and Methods
Chemicals and samples p-nitrophenyl-β-D-glucopyranoside (PNPG), pure sodium taurocholate (6 mg/ml), Triton X-100, glucose, and D-gluconolactone (D-glucono-1,5-lactone), were obtained from Sigma-Aldrich (Germany). Additionally, we used pure sodium acetate buffer (50 mM; 0.4355% w/v CH 3 COO Na/, 0.1089% w/v CH 3 COOH, pH 5), and lysis buffer (155 mmol/L NH 4 Cl; 10 mmol/L NaHCO 3 ; 0.1 mmol/L EDTA) obtained from Semikem (Bosnia and Herzegovina). Blood samples were acquired using the guidelines and approval of the University of Burch Research Ethics Committee (30052016). Written informed consent was obtained from two healthy adult male donors. Whole EDTA blood (10 ml) was collected aseptically.
Isolation of Leukocytes
Leukocytes were isolated by centrifugation after specific lysis of erythrocytes, according to the method of Peters et al. [42] . Aseptically collected whole EDTA blood (10 ml) was centrifuged at 1500g at 4°C for ten minutes, followed by the removal of plasma. The original blood volume was restored with 0.9% (w/v) NaCl solution and the blood suspension was transferred to a 50 ml conical centrifuge tube, followed by the addition of 40 ml cold hypotonic lysis buffer. The tube was left to stand on the ice and occasionally mixed for approximately ten minutes. The suspension was centrifuged again at 1500g at 4°C for five minutes. Leukocytes formed a small, firm pellet on the side of the tube while the erythrocyte ghosts formed a large loose pellet at the bottom of the tube. Both the hemoglobin-containing supernatant and the loose red cell ghosts were removed by aspiration using a Pasteur pipette. Leukocyte pellet was suspended in 5 ml cold hypotonic lysis buffer. The tube was left to stand on the ice. After 10 minutes, the cell suspension was diluted up to 50 ml with cold 0.9% (w/v) NaCl solution and centrifuged again at 1500g at 4°C for five minutes. The supernatant was discarded, and the leukocyte pellet was suspended in 10 ml 0.9% (w/v) NaCl solution followed by centrifugation at 1500g at 4°C for ten minutes. The supernatant was removed entirely, and samples were stored at -80°C for further use. A step by step protocol is uploaded at protocols.io (dx.doi.org/10.17504/protocols.io.bcv2iw8e) [54] 
Extraction of GCase from leukocyte pellet
GCase extraction protocol is modified from Kara et al. [55] . Leukocyte cell pellets equivalent to 10 ml of whole blood were thawed and suspended in 1.0 ml of 0.1% (v/v) detergent TritonX-100, and subjected to six cycles of freezing-thawing by alternating tubes, at approximately three-minute intervals, using a dry-ice/ethanol bath and water bath (-70°C / 27°C). The total homogenate was centrifuged at 2100g for 5 minutes at 10°C and supernatant was put into a clean tube in an ice bath for assay. Protein concentration was estimated by the Bradford method, using bovine serum albumin as standard [56] .
Leukocyte Glucosylceramidase Assay
Glucosylceramidase activity was determined spectrophotometrically using 140 μ l assay mixtures. The standard reaction mixture consisted of 70 μ l of enzyme solution and 70 μ l of 5 mM PNPG substrate in 50 mM sodium acetate buffer (pH 5.0), sodium taurocholate was dissolved in the substrate solution [30] . After incubation at 37°C for 45 min, the reaction was terminated by the addition of 70 μ l of 0.5 M sodium carbonate (Na 2 CO 3 , pH 10.3). Absorbance was read at 400 nm against the blank solution containing substrate buffer instead of the enzyme extract. One unit of GCase activity was defined as the amount of enzyme required to release one μ mol of p-nitrophenol from PNPG per minute (1 U), at 37°C and pH 5.0.
In vitro Inhibition Studies and Determination of Kinetic Parameters
All the samples were assayed in the presence of pure sodium taurocholate at pH 5.0. The substrate concentrations for each sample were: 0.71, 1.07, 1.43, 1.79, and 2.50 mmol per liter. Incubations were carried out at 37°C for 45 min. The K m and V max were obtained through the Lineweaver-Burk plot, whereby the best fit lines were calculated by linear regression analysis. Inhibition experiments were performed using PNPG as substrate, and different final concentrations of δ -gluconolactone, glucose as possible inhibitors. A double reciprocal Lineweaver-Burk plot was used to calculate the parameters. The activity of the β -Glucosylceramidase at four different concentrations of each inhibitor was determined by regression analysis. Results are expressed as % activity, assuming 100% enzyme activity in the absence of an inhibitor. In the presence of possible inhibitors, % activity was calculated by using the following equation: % activity = 100-
where A o is the initial GCase activity (without inhibitor), and A i is the GCase activity with the inhibitor. The inhibitor concentration that reduces the enzymatic activity by 50% (I 50 values) was determined from the plots.
Results and Discussion

GCase Extraction and Optimization of Stability
Protein studies require proper preservation of proteins in order to work with the same quality of protein throughout the steps [57] . We performed the optimization study for the stability of GCase in leukocyte homogenate in the course of storage in -20°C frost-free freezer. It was observed that the activity of GCase, exhibits only minor changes after ten and twenty days of storage, in the presence of pure sodium taurocholate ( Figure A1 ). In our study, GCase present in the crude protein extract was partially purified. However, the fact that cleavage of PNPG substrate is only possible by GCase, makes our way a convenient one to study the enzyme kinetics of GCase. Furthermore, UV-vis spectroscopy with an absorbance signal higher than 320nm is widely used to study protein preparations and monitoring enzyme activity [58] . In our case, the product of the catalyzed reaction, p-nitrophenol, was continuously released from PNPG, and this product strongly absorbed light at 400 nm [53] . With this theoretical framework, we developed a simple, cost-and time-efficient technique to study the activity of this enzyme with high importance in many diseases and industry.
Determination of Optimal pH
The conformational stability and catalytic activity of enzymes are in direct relationship to their pH [59] . To determine the optimal pH value for the hydrolysis of PNPG by leukocyte GCase, we examined the effects of variable pH (4.0-5.5) at a constant substrate concentration (5mM). Figure 1 .A shows the pH activity curve of leukocyte GCase assayed in the presence of sodium taurocholate. Leukocyte GCase was optimally active at pH 5.1, after which the enzyme activity started to decline (Figure 1.B) . The optimal pH of GCase activity from different sources and different substrate is reported to be in 4.7-5.9 intervals [60] , which is consistent with its lysosomal function and our finding.
Determination of Glucosylceramidase Km and Vmax for PNPG substrate
The Michaelis constant (K m ) is a measure of the affinity of the enzyme towards the substrate, with smaller values representing higher affinity. The Michaelis constant (K m ) and the maximum rate (V max ) of leukocyte GCase were obtained through the Lineweaver-Burk plot (Figure 1.B) with artificial substrate PNPG in concentrations ranging from 0.71 mM to 2.50 mM. K m and V max values were found to be 12.6 mM and 333 U/mg, respectively, in reasonable agreement with previously reported (593 mM) studies [53] .
In vitro Enzyme Inhibitor Studies
The inhibition study was performed using the PNPG as a substrate. Inhibitors were defined to be gluconolactone and glucose. The results indicated that gluconolactone was the most effective inhibitor acting in competitively with a IC 50 value of 0.047 mM (Figure 2 .A) and K i value of 0.023 mM ( Figure 2B ). The changing apparent K m to higher values in higher gluconolactone concentrations is an indicator of competitive inhibition ( Table 2) . A report from placental cells has shown similar results [45] . However, as can be seen in Table 2 , glucose was shown to be an uncompetitive inhibitor of PNPG hydrolysis, with a IC 50 value of 55.3 mM ( Figure  3A ) and K i value of 1.94 mM ( Figure 3B ). Based on literature, this is the first study to investigate gluconolactone and glucose inhibition in human leukocyte GCase. However, the inhibition kinetics of β -glucosidase (EC3.2.1.21) from several plants, fungi and especially microorganisms [62] [63] [64] [65] [66] has extensively been studied using glucose as an inhibitor, since glucose inhibition of β -glucosidase is undesirable if the enzymatic hydrolysis of cellulose is performed as an industrial process [67, 68] . 
